Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus.

Hendra virus (HeV) continues to cause morbidity and mortality in both humans and horses with a number of sporadic outbreaks. HeV has two structural membrane glycoproteins that mediate the infection of host cells: the attachment (G) and the fusion (F) glycoproteins that are essential for receptor binding and virion-host cell membrane fusion, respectively. N-linked glycosylation of viral envelope proteins are critical post-translation modifications that have been implicated in roles of structural integrity, virus replication and evasion of the host immune response. Deciphering the glycan composition and structure on these glycoproteins may assist in the development of glycan-targeted therapeutic intervention strategies. We examined the site occupancy and glycan composition of recombinant soluble G (sG) glycoproteins expressed in two different mammalian cell systems, transient human embryonic kidney 293 (HEK293) cells and vaccinia virus (VV)-HeLa cells, using a suite of biochemical and biophysical tools: electrophoresis, lectin binding and tandem mass spectrometry. The N-linked glycans of both VV and HEK293-derived sG glycoproteins carried predominantly mono- and disialylated complex-type N-glycans and a smaller population of high mannose-type glycans. All seven consensus sequences for N-linked glycosylation were definitively found to be occupied in the VV-derived protein, whereas only four sites were found and characterized in the HEK293-derived protein. We also report, for the first time, the existence of O-linked glycosylation sites in both proteins. The striking characteristic of both proteins was glycan heterogeneity in both N- and O-linked sites. The structural features of G protein glycosylation were also determined by X-ray crystallography and interactions with the ephrin-B2 receptor are discussed.

[1]  D. Stuart,et al.  Dimeric Architecture of the Hendra Virus Attachment Glycoprotein: Evidence for a Conserved Mode of Assembly , 2010, Journal of Virology.

[2]  R. Lamb,et al.  Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures , 2005, Virology.

[3]  C. Broder,et al.  Receptor Binding, Fusion Inhibition, and Induction of Cross-Reactive Neutralizing Antibodies by a Soluble G Glycoprotein of Hendra Virus , 2005, Journal of Virology.

[4]  M. Jones,et al.  Peptide map analysis of recombinant human granulocyte colony stimulating factor: elimination of methionine modification and nonspecific cleavages. , 1994, Analytical biochemistry.

[5]  V. Panin,et al.  Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes. , 2010, Seminars in cell & developmental biology.

[6]  D. Stuart,et al.  Cells under siege: Viral glycoprotein interactions at the cell surface , 2011, Journal of structural biology.

[7]  R. Dutch,et al.  Role of N-Linked Glycosylation of the Hendra Virus Fusion Protein , 2005, Journal of Virology.

[8]  C. Broder,et al.  A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats , 2008, Vaccine.

[9]  Z. Shriver,et al.  Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug product. , 2011, Journal of pharmaceutical and biomedical analysis.

[10]  J. Peter-Katalinic,et al.  Methods in enzymology: O-glycosylation of proteins. , 2005, Methods in enzymology.

[11]  Pan-Jun Kim,et al.  Centralized Modularity of N-Linked Glycosylation Pathways in Mammalian Cells , 2009, PloS one.

[12]  K. Mehta,et al.  N-linked glycosylation of CD38 is required for its structure stabilization but not for membrane localization , 2006, Molecular and Cellular Biochemistry.

[13]  N. Sharon,et al.  Protein glycosylation. Structural and functional aspects. , 1993, European journal of biochemistry.

[14]  C. Broder,et al.  Identification of Hendra Virus G Glycoprotein Residues That Are Critical for Receptor Binding , 2007, Journal of Virology.

[15]  The N-terminal 22 amino acids encoded by the gene specifying the major secreted protein of vaccinia virus, strain Lister, can function as a signal sequence to direct the export of a foreign protein. , 1992, Virus research.

[16]  Joseph Zaia,et al.  Mass spectrometry and glycomics. , 2010, Omics : a journal of integrative biology.

[17]  B. Eaton,et al.  The Exceptionally Large Genome of Hendra Virus: Support for Creation of a New Genus within the FamilyParamyxoviridae , 2000, Journal of Virology.

[18]  G. Simmons,et al.  Viral Entry into Host Cells , 2013, Advances in Experimental Medicine and Biology.

[19]  S. Strahl,et al.  Protein O-mannosylation: conserved from bacteria to humans. , 2009, Glycobiology.

[20]  Kai Xu,et al.  Host cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3 , 2008, Proceedings of the National Academy of Sciences.

[21]  C. Broder,et al.  Hendra and Nipah viruses: pathogenesis and therapeutics. , 2005, Current molecular medicine.

[22]  Barbara Imperiali,et al.  Asparagine-linked protein glycosylation: from eukaryotic to prokaryotic systems. , 2006, Glycobiology.

[23]  H. Field,et al.  Nipah virus: a recently emergent deadly paramyxovirus. , 2000, Science.

[24]  D. Jarvis,et al.  Letter to the Glyco-Forum: Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities , 2011 .

[25]  R. Lamb,et al.  Domain architecture and oligomerization properties of the paramyxovirus PIV 5 hemagglutinin-neuraminidase (HN) protein. , 2008, Virology.

[26]  S. Brooks Appropriate glycosylation of recombinant proteins for human use , 2004, Molecular biotechnology.

[27]  Barbra A. Richardson,et al.  Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses , 2007, Journal of Virology.

[28]  Randy J. Read,et al.  Dauter Iterative model building , structure refinement and density modification with the PHENIX AutoBuild wizard , 2007 .

[29]  David I Stuart,et al.  Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2 , 2008, Nature Structural &Molecular Biology.

[30]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[31]  V. Shepherd,et al.  Virus glycosylation: role in virulence and immune interactions , 2007, Trends in Microbiology.

[32]  Meir Shinitzky,et al.  Structural and functional aspects , 1994 .

[33]  J. Epstein,et al.  Nipah virus: Impact, origins, and causes of emergence , 2006, Current infectious disease reports.

[34]  N. Callewaert,et al.  N-glycosylation engineering of biopharmaceutical expression systems. , 2009, Current molecular medicine.

[35]  Lin-Fa Wang,et al.  Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Broder,et al.  Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine , 2006, Journal of Virology.